Astrin Biosciences is a cancer intelligence company built to push the boundaries of technology – accelerating early detection and advancing cancer care. Astrin’s breakthrough cancer tests analyze the early signals in over 8,000 proteins to reveal what most tests miss: the earliest molecular signals in cancer development.
Astrin Biosciences was founded on a bold idea: that health decisions should be based not just on what’s happening inside the body, but on the reality of the person living in it.
Our Mission us to lead in cancer intelligence and early detection.
Company Details
- Employees
- 28
- Founded
- -
- Address
- St. Paul, Mn 55114, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://astrinbio.com
- Keywords
- oncology, biotechnology, AI, Machine Learning, precision medicine, start-up, metastasis, early stage, proteomics, liquidbiopsy, deeplearning, Cancer screening, Breast Cancer, Blood Test.
- HQ
- St. Paul, MN
Astrin Biosciences Questions
Astrin Biosciences's website is http://astrinbio.com
Astrin Biosciences's LinkedIn profile is https://www.linkedin.com/company/astrin-biosciences
Astrin Biosciences has
28 employees.
View email and phone details for 28
employees at Astrin Biosciences.
Astrin Biosciences's industry is
Biotechnology Research
Astrin Biosciences's top competitors are
Dahl Consulting,
Particle4x,
Natera,
Oncodea,
Allina Health,
Mammoth Biosciences,
Exact Sciences,
Sana Biotechnology, Inc.,
Caribou Biosciences,
Pinkdx, Inc..
Astrin Biosciences's categories are Biotechnology Research
Astrin Biosciences's founding year is 2021
